Fervent Pharmaceuticals   Report issue

For profit Phase 2
Founded: Greenville NC United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2018
NCT03285672
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fervent Pharmaceuticals